Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study

被引:155
作者
Wiman, B [1 ]
Andersson, T
Hallqvist, J
Reuterwall, C
Ahlbom, A
deFaire, U
机构
[1] Karolinska Hosp, Dept Clin Chem, S-17176 Stockholm, Sweden
[2] Karolinska Hosp, Div Cardiovasc Med, S-17176 Stockholm, Sweden
[3] Karolinska Inst, Inst Environm Med, Dept Epidemiol, S-10401 Stockholm, Sweden
[4] Karolinska Inst, Inst Environm Med, Dept Cardiovasc Epidemiol, S-10401 Stockholm, Sweden
[5] Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden
关键词
fibrinolysis; hemostasis; myocardial infarction; risk markers;
D O I
10.1161/01.ATV.20.8.2019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An impaired fibrinolytic function due to elevated plasma levels of plasminogen activator inhibitor (PAI)-1 activity or tissue plasminogen activator (tPA) antigen is correlated with the development of myocardial infarction (MI) in patients with manifest coronary heart disease. Recently, methods for determining the specific tPA/inhibitor complexes constituting tPA antigen in plasma have become available. In the Stockholm Heart Epidemiology Program (SHEEP) study, 86 of 1212 MI patients, subjected to blood sampling in a metabolically stable period, suffered reinfarction before the end of 1996. These individuals have been compared with an approximately equal number of matched MI patients without recurrence and a group of matched healthy control subjects regarding the plasma concentrations of some hemostatic factors. The hemostatic compounds studied (fibrinogen, von Willebrand factor, tPA antigen, PAI-1, and the tPA/PAI-1 complex) were typically higher in the groups (men and women) with recurrence of MI compared with those without. The plasma concentrations were also typically higher in the pooled groups of patients compared with the groups of healthy control subjects. The largest between-group differences were found for the plasma tPA/PAI-1 complex. The crude odds ratio for reinfarction associated with higher concentration (greater than or equal to 75th percentile among the control subjects) of tPA/PAI-1 was 1.8 (95% CI 1.1 to 3.1); the corresponding crude odds ratio for von Willebrand factor was 2.3 (1.3 to 4.0). The tPA/PAI-1 complex correlated strongly with PAI-1 and tPA antigen in all groups and with serum triglycerides and body mass index in all groups except for women with reinfarction. An increased plasma level of tPA/PAI-1 complex is a novel risk marker for recurrent MI in men and women. Most likely, increased plasma levels of tPA/PAI-1 complex reflect impaired fibrinolysis, because the correlation with PAI-1 is strong. Further support is obtained indicating that the plasma concentration of von Willebrand factor is also an important risk marker for recurrent MI.
引用
收藏
页码:2019 / 2023
页数:5
相关论文
共 17 条
[1]   INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
MUSSONI, L ;
DONATI, MB ;
CARDILLO, M ;
CATALANO, M ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
POZZOLI, E ;
TURRI, M ;
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
CARDILLO, M ;
TORRI, M ;
RAINISIO, M ;
GENTILE, G ;
MOREO, G ;
BIANCHI, O ;
LEONARDI, P ;
COLOMBI, M ;
CATALANO, M ;
GALIMBERTI, P ;
RUSSO, U ;
CRESSOTTI, A ;
CARZANIGA, G ;
NOBILI, S ;
NINNO, D ;
DONATI, MB ;
IACOVIELLO, L ;
DEGAETANO, G ;
GABRIELLI, L ;
MARTELLI, E ;
CORSI, G ;
LORENZI, G ;
LOMBARDI, B ;
CARRIERO, MR ;
COLOMBO, R ;
SPECCHIA, G ;
CIOFFI, P ;
SCIRE, A ;
TAVAZZI, L ;
GIANNUZZI, P ;
CORRA, U ;
TEMPORELLI, L ;
MORA, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417
[2]  
HAMSTEN A, 1987, LANCET, V2, P3
[3]   INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION [J].
HAMSTEN, A ;
WIMAN, B ;
DEFAIRE, U ;
BLOMBACK, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) :1557-1563
[4]   Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol - Results from the angina prognosis study in Stockholm [J].
Held, C ;
Hjemdahl, P ;
Rehnqvist, N ;
Wallen, H ;
Bjorkander, I ;
Eriksson, SV ;
Forslund, L ;
Wiman, B .
CIRCULATION, 1997, 95 (10) :2380-2386
[5]  
JANSSON JH, 1991, BRIT HEART J, V66, P351
[6]   PREDICTIVE VALUE OF TISSUE-PLASMINOGEN ACTIVATOR MASS CONCENTRATION ON LONG-TERM MORTALITY IN PATIENTS WITH CORONARY-ARTERY DISEASE - A 7-YEAR FOLLOW-UP [J].
JANSSON, JH ;
OLOFSSON, BO ;
NILSSON, TK .
CIRCULATION, 1993, 88 (05) :2030-2034
[7]   TISSUE PLASMINOGEN-ACTIVATOR AND OTHER RISK-FACTORS AS PREDICTORS OF CARDIOVASCULAR EVENTS IN PATIENTS WITH SEVERE ANGINA-PECTORIS [J].
JANSSON, JH ;
NILSSON, TK ;
OLOFSSON, BO .
EUROPEAN HEART JOURNAL, 1991, 12 (02) :157-161
[8]  
JUHANVAGUE I, 1987, DIABETES METAB, V13, P331
[9]   INCREASED PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS - A POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND ATHEROTHROMBOSIS [J].
JUHANVAGUE, I ;
ALESSI, MC ;
VAGUE, P .
DIABETOLOGIA, 1991, 34 (07) :457-462
[10]   INVOLVEMENT OF THE HEMOSTATIC SYSTEM IN THE INSULIN-RESISTANCE SYNDROME - A STUDY OF 1500 PATIENTS WITH ANGINA-PECTORIS [J].
JUHANVAGUE, I ;
THOMPSON, SG ;
JESPERSEN, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (12) :1865-1873